Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

To evaluate short and intermediate clinical outcome of different anti-thrombotic regimens on major adverse cardiac events (MACE) and quality of life in coronary artery ectasia patients.To evaluate role of P-selectin as a marker of cardiovascular risk in coronary artery ectasia.

Inclusion Criteria:all patients diagnosed with coronary artery ectasia either associated with obstructive or non-obstructive coronary artery disease after undergoing coronary angiography at cath. lab, cardiology department, Assiut university heart hospital, Assiut university.Exclusion Criteria:Atrial fibrillationLeft ventricular thrombussevere Valvular heart disease.Mechanical valve prothesisCrusade score ≥ 41 (high - very high risk)deep venous thrombosis, pulmonary embolismrenal failure stage IV-V.known malignancyEvidence of acute or chronic infection (by history or clinical examination).History of systemic inflammatory or autoimmune disease.History of any clinically significant endocrine, hematologic, respiratory, or metabolic diseases